AMYLOIDOSIS

Clinical trials for AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 19 Not yet recruiting 1 Not yet finished but already full! 3 Completed 5 Terminated 1

Weekly injection trial aims to halt debilitating heart disease

Disease control Terminated

This study tested whether weekly injections of a drug called inotersen could slow or stop the progression of a serious heart condition called TTR amyloid cardiomyopathy. The drug works by reducing the production of a problematic protein that builds up and damages the heart. Over …

Matched conditions: AMYLOIDOSIS

Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

AMYLOIDOSIS

Get alerted when new AMYLOIDOSIS trials appear

Weekly injection trial aims to halt debilitating heart disease